Home › RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
 

Keywords :   


RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials

2015-09-02 07:40:59| drugdiscoveryonline News Articles

RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)

Tags: lead clinical therapy candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »